Is Summit Therapeutics Inc. (SMMT) a Buy, Sell, or Hold?
NASDAQ : SMMT
Summit Therapeutics Inc. — Stock Grades
$12.655 USD
$0.1 (0.84%)
- Volume
- 852.24K
- Average Volume
- 5.25M
- Market Capitalization
- $9.82B
- P/E Ratio
- -11.30
- Dividend Yield
- 0.00%
- Price Target
- $23.00
- Year High
- $30.98
- Year Low
- $12.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.96
SMMT Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-24 | Stifel | Buy | Buy | Maintain |
| 2026-07-24 | Guggenheim | Buy | Buy | Maintain |
| 2026-07-23 | HC Wainwright & Co. | Neutral | Neutral | Maintain |
| 2026-05-22 | HC Wainwright & Co. | Buy | Neutral | Downgrade |
| 2026-05-04 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-05-01 | Piper Sandler | Neutral | Neutral | Maintain |
| 2026-04-08 | Stifel | Buy | Buy | Maintain |
| 2026-03-16 | Jefferies | Buy | Hold | Downgrade |
| 2026-02-24 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-02-02 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-01-30 | Citizens | Market Outperform | Market Outperform | Maintain |